Epidemiology and Survival of Kaposi’s Sarcoma by Race in the United States: A Surveillance, Epidemiology, and End Results Database Analysis by Ragi SD, Moseley I, Ouellette S, Rao B

Get full text

Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis. by Moreau, T, Thorpe, J, Miller, D, Moseley, I, Hale, G, Waldmann, H, Clayton, D, Wing, M, Scolding, N, Compston, A

Soluble E-selectin in multiple sclerosis: raised concentrations in patients with primary progressive disease. by Giovannoni, G, Thorpe, J, Kidd, D, Kendall, B, Moseley, I, Thompson, A, Keir, G, Miller, D, Feldmann, M, Thompson, E

CAMPATH-IH in multiple sclerosis. by Moreau, T, Coles, A, Wing, M, Thorpe, J, Miller, D, Moseley, I, Issacs, J, Hale, G, Clayton, D, Scolding, N, Waldmann, H, Compston, A

The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group. by Tubridy, N, Behan, P, Capildeo, R, Chaudhuri, A, Forbes, R, Hawkins, C, Hughes, R, Palace, J, Sharrack, B, Swingler, R, Young, C, Moseley, I, MacManus, D, Donoghue, S, Miller, D

The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group. by Tubridy, N, Behan, P, Capildeo, R, Chaudhuri, A, Forbes, R, Hawkins, C, Hughes, R, Palace, J, Sharrack, B, Swingler, R, Young, C, Moseley, I, MacManus, D, Donoghue, S, Miller, D